Walgreens Boots Alliance Inc. has agreed to pay $44 million to settle class action claims by consumers who received flawed blood tests in Arizona and California through the pharmacy chain’s partnership with Theranos Inc.
The proposed settlement, which needs court approval, will provide consumers who participated in the lawsuit with “approximately double their out-of-pocket damages,” lawyers for plaintiffs said in a court filing Wednesday in federal court in Phoenix.
The lawsuit accused Walgreens of being “willfully blind” to fraud at Theranos and entering into a partnership with the startup even though it had good reason to suspect its finger-prick testing technology didn’t really work.
Read more at News.law
